|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||10.61 - 10.61|
|52-week range||10.61 - 33.48|
|Beta (5Y monthly)||2.22|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
At this time, I'll now turn the conference over to Eric Dutang, Chief Financial Officer. Thank you, and welcome everyone to Cellectis' second quarter 2021 corporate update and financial results conference call. Joining me on the call today with prepared remarks is Dr. Andre Choulika, our Chief Executive Officer; Dr. Carrie Brownstein, our Chief Medical Officer; and Steve Doares, our Senior Vice President of U.S. Manufacturing will be joining for the Q&A.
Enthusiasm for life-sciences stocks may be at an all-time high, but it's easy to lose your shirt when dealing with companies on the cutting edge like Calyxt (NASDAQ: CLXT) and Zymergen (NASDAQ: ZY). Both of these companies have huge potential for growth, but investors probably want to watch them from a safe distance for now. After discussing what to avoid, I'll also show you why Thermo Fisher Scientific (NYSE: TMO) is one of the best life-sciences stocks you can buy now.
CLLS earnings call for the period ending December 31, 2020.